Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit

被引:129
作者
Pournaras, S
Markogiannakis, A
Ikonomidis, A
Kondyli, L
Bethimouti, K
Maniatis, AN
Legakis, NJ
Tsakris, A [1 ]
机构
[1] Univ Athens, Sch Med, Dept Microbiol, Athens 11527, Greece
[2] Univ Thessaly, Sch Med, Dept Microbiol, Larisa, Greece
[3] Red Cross Hosp, Dept Clin Microbiol, Athens, Greece
关键词
oxacillinase; carbapenems; bla(OXA-51); bla(OXA-58); RT-PCR;
D O I
10.1093/jac/dkl004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To investigate the resistance mechanisms and the genetic relationship of imipenem-resistant Acinetobacter baumannii isolates recovered in the intensive care unit (ICU) of a tertiary care hospital. Methods: Imipenem-resistant A. baumannii clinical and environmental isolates were collected in the ICU of the Red Cross General Hospital, Athens, Greece between March and October 2002. The isolates were tested by Etest MBL, PCR, RT-PCR and sequencing for carbapenemase-encoding genes, PFGE and synergy experiments using meropenem and the efflux pump inhibitor carbonyl cyanide chlorophenylhydrazone. Results: During the study period, 15 clinical and two environmental imipenem-resistant (MIC 8 to > 128 mg/L) A. baumannii isolates were recovered. PFGE showed six different clones that included both clinical and environmental isolates. All 17 isolates were negative by Etest MBL and PCR for genes bla(IMP), bla(VIM), bla(SPM), bla(OXA-23-like) and bla(OXA-24-like). Genes bla(OXA-51-like) and bla(OXA-58-like) were amplified from 15 and 14 isolates, respectively. Sequencing of bla(OXA-51-like) amplicons identified bla(OXA-66) (nine cases) and bla(OXA-69) (six cases), whereas bla(OXA-58-like) sequences were classical bla(OXA-58). Reverse transcriptase-PCR showed that bla(OXA-51-like) genes were expressed in 12 and bla(OXA-58) in 10 isolates; in these isolates, inhibition of OXA enzymes by 200 mM of NaCl reduced carbapenem MICs by up to 4-fold. Overexpression of proton-gradient dependent efflux pumps did not contribute to carbapenem resistance in any isolate. Similarly, although AmpC expression was demonstrated in eight isolates, inhibition of AmpC with cloxacillin did not reduce the MICs of carbapenems significantly. Conclusions: These findings indicate wide dissemination of OXA-58 carbapenemase, which contributes, at least partially, to the imipenem resistance of unrelated A. baumannii isolates in our ICU.
引用
收藏
页码:557 / 561
页数:5
相关论文
共 14 条
[1]   The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents [J].
Brown, S ;
Amyes, SGB .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (04) :326-329
[2]   Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina [J].
Brown, S ;
Young, HK ;
Amyes, SGB .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (01) :15-23
[3]   AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains [J].
Corvec, S ;
Caroff, N ;
Espaze, E ;
Giraudeau, C ;
Drugeon, H ;
Reynaud, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (04) :629-635
[4]   Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii [J].
Héritier, C ;
Poirel, L ;
Lambert, T ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) :3198-3202
[5]   Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii [J].
Héritier, C ;
Poirel, L ;
Fournier, PE ;
Claverie, JM ;
Raoult, D ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (10) :4174-4179
[6]  
Livermore David M, 2002, Curr Opin Investig Drugs, V3, P218
[7]   Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe [J].
Marqué, S ;
Poirel, L ;
Hériteir, C ;
Brisse, S ;
Blasco, MD ;
Filip, R ;
Coman, G ;
Naas, T ;
Nordmann, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) :4885-4888
[8]   OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii [J].
Poirel, L ;
Marqué, S ;
Héritier, C ;
Segonds, C ;
Chabanon, G ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (01) :202-208
[9]   Spread of efflux pump-overexpressing, non-metallo-β-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity [J].
Pournaras, S ;
Maniati, M ;
Spanakis, N ;
Ikonomidis, A ;
Tassios, PT ;
Tsakris, A ;
Legakis, NJ ;
Maniatis, AN .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (04) :761-764
[10]   Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City [J].
Quale, J ;
Bratu, S ;
Landman, D ;
Heddurshetti, R .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) :214-220